John R Stuelpnagel sold $1.2M of 10x Genomics (TXG)

Executed Aug 11, disclosed Aug 13, 2 days later.

Value, as filed

$1.2M

20,000 sh across 2 lots

Executed

Aug 11

the trade date, as filed

Disclosed

Aug 13

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

John R Stuelpnagel Director profile →

John R Stuelpnagel (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in 10x Genomics, Inc. (TXG). The largest single filing was $1.2M of TXG (20,000 sh across 3 lots, as filed), executed Sep 3.

The name

TXG

10x Genomics, Inc. TXG · Healthcare · 30 filings in 24 months ticker →

Healthcare · 10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by John R Stuelpnagel in TXG

TXGSALE 10x Genomics, Inc. $1.2M
20,000 sh across 3 lots
Exec Sep 3
Filed Sep 8 · 7:00 PM ET